Wednesday, January 29, 2020

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues.

from Moneycontrol Business News https://ift.tt/2RCYxBJ
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Dollar stays near 18-month high as Mideast conflict, inflation data in focus

The dollar's steadiness reflects a cautious market responding to geopolitical stresses in the Middle East, which have dampened investor ...